Marius Pearson
Part-funded by Oxford PharmaGenesis, ‘Our Big MS Adventure’ uniquely shows the impact of multiple sclerosis over 12 years, highlighting breakthroughs in treatment, and sharing emotive personal journeys.
Share this page Overview Day 1 report Day 2 report Day 3 report Day 2 key take-homes and insights Opening remarks & keynote – writing for equity & inclusion: the role of empathy in medical communications – Georgia Palmer (Project Coordinator, Oxford PharmaGenesis) Medical communications are reaching a wider audience than ever before, including diverse […]
Richard White, COO of Oxford PharmaGenesis, provides his expert insights on health economics and outcomes research (HEOR) publications and open access in a new article from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading global professional society for HEOR.
Share this page Overview Day 1 report Day 2 report Day 3 report Day 1 key take-homes and insights Unused vaccines can’t save lives – embracing an opportunity to overcome vaccination hesitancy in the midst of a global pandemic – Alan Cowland (Medical Writer, Oxford PharmaGenesis) The response to the COVID-19 pandemic clearly demonstrates that […]
Share this page Overview Day 1 report Day 2 report Day 3 report Oxford PharmaGenesis at the Virtual 17th Annual Meeting of ISMPP Company overview video ISMPP is a fantastic opportunity to share best practice and connect with people who share our vision for what medical publications and communications can achieve. Chris Winchester, CEO Presentations […]
Last week marked the fourth Informatics Summit from the American Medical Informatics Association (AMIA). The meeting provided a fantastic opportunity for members of our Informatics and Data Science practice to stay up to date with the latest developments in the fields of artificial intelligence (AI), natural language processing and machine learning in the context of […]
The Friends of the US National Library of Medicine has elected Chris Winchester, CEO of Oxford PharmaGenesis, to its Board of Directors in recognition of the growing collaboration between the two organizations. The move bodes well for the disclosure and dissemination of medical evidence from the pharmaceutical industry and beyond.
For the fourth year in a row, Oxford PharmaGenesis has been listed in the Alantra Pharma Fast 50 as one of the UK’s fastest-growing, privately owned pharmaceutical businesses.
Today I’m attending the online Women in Data Science Worldwide Conference, along with tens of thousands of professionals, speakers, ambassadors and thought leaders reports Hollie Rawlings (Data Analyst – Informatics and Data Science).
With the challenges presented over the past year, keeping in touch has been more important than ever. The COVID-19 pandemic has affected us all in different ways, and a short conversation with a colleague, friend or family member about mental health has the power to make a big difference.
